After two years of negotiations, FDA gets its user fee programs authorized through 2022
President Donald Trump signed the FDA Reauthorization Act of 2017 into law late Friday, quietly ending a two-year long process that until several …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
